Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amy Wheless
Observed names:
A Wheless,
Amy A. Wheless,
Wheless, A,
Wheless, Amy,
Wheless, Amy A.
Institution:
University of North Carolina at Chapel Hill
Observed institutions:
University of North Carolina at Chapel Hill,
Western General Hospital,
Institute of Genetics and Cancer,
UNC Lineberger Comprehensive Cancer Center,
University of Edinburgh
OpenAlex ID:
A5011522141
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis
2022
·
Susana Garcia-Recio
, Toshinori Hinoue
, et al.
·
Nature Cancer
·
116
PDF
Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer
2020
·
Kirsten A. Nyrop
, Emily M. Damone
, et al.
·
Cancer
·
40
PDF
Weight trajectories in women receiving systemic adjuvant therapy for breast cancer
2019
·
Kirsten A. Nyrop
, Allison M. Deal
, et al.
·
Breast Cancer Research and Treatment
·
37
PDF
A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience
2015
·
Megan J. McKee
, Kevin Keith
, et al.
·
The Oncologist
·
34
Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer
2022
·
Danielle M. File
, Tomas Pascual
, et al.
·
Breast Cancer Research and Treatment
·
27
Weight changes in postmenopausal breast cancer survivors over 2 years of endocrine therapy: a retrospective chart review
2017
·
Kirsten A. Nyrop
, Allison M. Deal
, et al.
·
Breast Cancer Research and Treatment
·
25
PDF
Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else?
2017
·
Kirsten A. Nyrop
, Allison M. Deal
, et al.
·
Breast Cancer Research and Treatment
·
13
PDF
Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419
2022
·
Eric D. Routh
, Amanda E. D. Van Swearingen
, et al.
·
Frontiers in Oncology
·
12
Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution
2024
·
Selena J. An
, Christine Hong Ngoc Che Thai
, et al.
·
Annals of Surgical Oncology
·
6
PDF
Understanding metastasis mixed-treatment responses through genomic analyses
2025
·
Susana Garcia-Recio
, Paola Zagami
, et al.
·
npj Breast Cancer
·
4
PDF
Abstract PO4-10-04: Treatment differences by race and age in metastatic hormone receptor-positive/HER2-negative breast cancer
2024
·
Yara Abdou
, Joannie Ivory
, et al.
·
Cancer Research
·
1
The contribution of clinical subtype to survival differences among patients with de novo and recurrent metastatic breast cancer (dMBC).
2020
·
Danielle Marie File
, Tomas Pascual
, et al.
·
Journal of Clinical Oncology
·
1
ASO Visual Abstract: Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution
2024
·
Selena J. An
, Christine Hong Ngoc Che Thai
, et al.
·
Annals of Surgical Oncology
Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer
2024
·
Wheless, A
, File, D.M
, et al.
·
Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Abstract PO4-06-04: Understanding metastasis mixed-treatment responses through genomic analyses
2024
·
Susana Garcia-Recio
, Paola Zagami
, et al.
·
Cancer Research
Distribution and outcomes of HER2-low and HER2-zero metastatic breast cancer in Black and younger women.
2023
·
Paola Zagami
, Yara Abdou
, et al.
·
Journal of Clinical Oncology
PDF
Bsci-06 Comprehensive Analysis of the Immunogenomics of Triple Negative Breast Cancer Brain Metastases From Lccc1419
2022
·
Amanda Van Swearingen
, Eric Routh
, et al.
·
Neuro-Oncology Advances
Clinical Subtype, Treatment Response, and Survival in De Novo and Recurrent Metastatic Breast Cancer
2022
·
Danielle File
, Tomas Pascual
, et al.
·
Research Square
PDF
Abstract P1-17-05: Benefit of endocrine therapy for metastatic breast cancer after loss of hormone receptor expression in patients with HR+/HER2- primary tumors
2022
·
Danielle File
, Yara Abdou
, et al.
·
Cancer Research
A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience
2020
·
Benbow, Julie M.
, Dees, E. Claire
, et al.
·
Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Abstract P5-04-27: Investigating the incidence of ESR1 gene amplification in breast cancers resistant to multiple endocrine agents
2019
·
AK Turnbull
, C Martinez-Perez
, et al.
·
Cancer Research
Abstract P5-04-14: Tracking ESR1 mutation clonal evolution in breast cancer using in situ mutation detection
2019
·
C Martinez-Perez
, AK Turnbull
, et al.
·
Cancer Research
Abstract P4-03-01: Causes of endocrine therapy resistance: An in-depth genomic analysis of resistant multidrug ER+ breast cancers
2018
·
JM Dixon
, AK Turnbull
, et al.
·
Cancer Research
Weight trajectories during first two years of endocrine treatment: Premenopausal compared to postmenopausal early breast cancer survivors.
2017
·
Kirsten A Nyrop
, Allison Mary Deal
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
25
Citation count:
316
H-index:
8
I10-index:
8
Year
Topic
Type
